Related Experiment Video
Updated: Sep 11, 2025

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
In silico generation of synthetic cancer genomes using generative AI
Ander Díaz-Navarro1, Xindi Zhang2, Wei Jiao2
1Ontario Institute for Cancer Research, Toronto, ON, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
OncoGAN, a novel generative AI, creates realistic synthetic cancer genomes to overcome privacy barriers. This enables better benchmarking and improvement of cancer genome analysis tools.
Area of Science:
- Computational biology
- Genomics
- Artificial intelligence
Background:
- Genomic alterations are crucial for understanding cancer and advancing precision oncology.
- Privacy concerns limit the sharing of deeply sequenced cancer genomes, hindering algorithm development and benchmarking.
- Accurate algorithms are essential for detecting genomic alterations, but their improvement is impeded by data scarcity.
Purpose of the Study:
- To develop a generative artificial intelligence (AI) model for creating realistic synthetic cancer genomes.
- To address the challenge of limited data sharing in cancer genomics due to privacy concerns.
- To generate privacy-preserving synthetic cancer genome datasets for benchmarking and improving analytical tools.
Main Methods:
- Developed OncoGAN, a generative AI model utilizing adversarial networks and variational autoencoders.
- Trained OncoGAN on large-scale genomic datasets to learn patterns of somatic mutations, copy number alterations, and structural variants.
- Validated the fidelity of synthetic genomes using the DeepTumour tool, assessing concordance with real tumor data.
Main Results:
- OncoGAN accurately reproduces key genomic alterations, including somatic mutations, copy number alterations, and structural variants.
- Generated synthetic genomes reflect cancer-specific mutational signatures and positional mutation patterns.
- Synthetic data augmentation improved the accuracy of the DeepTumour analysis tool.
Conclusions:
- OncoGAN effectively generates realistic, privacy-preserving synthetic cancer genomes.
- The synthetic data can be used to augment real datasets, enhancing the performance of cancer genome analysis tools.
- OncoGAN offers a solution for creating shareable datasets with known ground truths, facilitating benchmarking and advancing cancer research.
Related Concept Videos
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Non-equilibrium in the Cell
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mutagenicity and Carcinogenicity
Cancers Originate from Somatic Mutations in a Single Cell

